Sinistral portal hypertension (SPH) or left-sided portal hypertension occurs as a result of isolated obstruction of the splenic vein. In the majority of the cases, it is a complication of a pancreatic pathology [1, 2] . In contrast to generalized portal hypertension, in patients with SPH, liver function tests and portal vein pressure are within normal limits. Expected flow direction in portal vein is hepatopetal [3e6].
Sinistral portal hypertension (SPH) or left-sided portal hypertension occurs as a result of isolated obstruction of the splenic vein. In the majority of the cases, it is a complication of a pancreatic pathology [1, 2] . In contrast to generalized portal hypertension, in patients with SPH, liver function tests and portal vein pressure are within normal limits. Expected flow direction in portal vein is hepatopetal [3e6] .
Splenic vein occlusion (SVO) leads to splenic venous congestion, which can cause splenomegaly and splenoportal collateral vessels develop in order to drain blood beyond the occluded splenic vein [7e9] . Owing to anatomic variants of venous anatomy, to underlying causative pathology and to site and duration of the disease, the observed collateral route varies among patients with splenic vein obstruction [10, 11] .
It has been reported that patients with SPH are usually asymptomatic and experience no complications; hence, the true incidence of this syndrome is unknown [12, 13] . Symptomatic patients may present with acute or chronic gastrointestinal bleeding, abdominal pain, or chronic anemia [13, 14] . Diagnosis of this disease is made by exclusion of generalized portal hypertension and should be considered in patients with upper gastrointestinal bleeding, normal liver function test results, and splenomegaly [1] . However, with improvement in diagnostic imaging procedures, recognition of SPH seems to be increasing even in asymptomatic patients.
Computed tomography (CT) is the imaging technique of choice to diagnose pancreatic pathologies, which are the most common associated pathology in SPH [1, 9, 12] . Therefore, CT imaging, performed to evaluate a pancreatic pathology, may demonstrate the findings of SPH in asymptomatic patients.
Herein, we aimed to demonstrate the CT imaging features of SPH and its clinical appearance in a descriptive case series.
Materials and Methods
The Institutional Ethics Committee approved this retrospective study protocol and waived informed consent.
Patient Population
We evaluated 41 consecutive patients with splenic vein occlusion who underwent CT imaging in our department between July 2011eJune 2016. Fifteen patients with portal vein thrombosis distal to portosplenic confluence and 2 patients with the diagnosis of liver cirrhosis were excluded. Thus, 24 patients were enrolled in this retrospective study.
Medical records of these patients were investigated from the database of our institution. The etiology of SPH, symptoms of the patients, laboratory findings indicative of hypersplenism (isolated thrombocytopenia or pancytopenia), anemia, and, if performed, upper gastrointestinal tract endoscopy results were noted.
Diagnosis of SPH was based on the presence of splenic vein occlusion accompanied by splenoportal collaterals without any imaging or clinical findings and laboratory (elevated ALT or AST, positive screen for serologic markers of liver disease) features of liver cirrhosis according to their electronic medical records and CT images.
CT Imaging Technique
CT images were obtained with 1 of 3 CT units: 1 64detector-row CT system (Aquilion, Toshiba Medical Systems, Ootawara, Japan) and 2 16-detector-row CT systems (Somatom Emotion 2007, Siemens, Munich, Germany; Bright Speed Delight, General Electric Healthcare, Milwaukee, WI).
Abdominal CT imaging was performed 60e80 seconds after 100 mL intravenous bolus injection of a nonionic iodinated contrast agent (Ioheksol) (350 mg/mL) at a rate of 2e4 mL/sec. Z-axis coverage extended from the diaphragm to the ischial tuberosities. CT imaging parameters are detailed in Table 1 .
Image Interpretation
CT images retrieved from a Picture Archiving and Communication System (PACS; Centricity, Version 5.0 RISi, GE Healthcare) were retrospectively analyzed in consensus by 2 radiologists with 5 and 17 years of experience in abdominal radiology. In addition to the axial images, multiplanar reformatted images and minimum intensity projection images were reviewed. Pancreas and neighbouring structures and retroperitoneum were carefully examined for the underlying cause of the splenic vein occlusion. Gastric, perigastric, omental, and esophageal collaterals were noted. Special attention was paid to gastroepiploic veins (GEV), coronary vein, and fundal varices. Gastroepiploic vein diameters !5 mm, coronary vein diameters ! 5 mm, and any observable veins in gastric wall were considered as enlarged.
The dimensions of the spleen were measured and splenic volume was estimated via the equation suggested by Prassopoulos et al [13] 
dimension on axial scan; T ¼ Max. thickness on axial scan)]. A normal value was considered between 110 mL-340 mL. Venous collaterals, splenic volume, and underlying pathologies were reported via descriptive statistics.
Results
There were 15 male and 9 female patients with a mean age of 56.9 years (age range, 24e87 years; median, 56.5 years).
Etiology of splenic vein thrombosis was pancreatic adenocarcinoma in 13 patients (54.2%), pancreatic pseudocyst in 3 patients (12.5%), chronic pancreatitis in 2 patients (8.3%), necrotizing pancreatitis in 1 patient (4.2%), pancreatic metastasis in 2 patients (8.4%), retroperitoneal abscess in 1 patient (4.2%), lymphoma in 1 patient (4.2%), and idiopathic splenic vein thrombosis in 1 patient (4.2%).
In 17 of the 24 patients, isolated splenic vein occlusion was present without any extension into spleno-mesenteric confluence. In this group, CT revealed gastric varices (n ¼ 10, 58.8%) (isolated fundal varices in 7 patients and varices both in fundus and corpus of the stomach in 3 patients), collateralized right and left gastroepiploic veins (n ¼ 14, 82.4%), coronary vein (n ¼ 12, 70.6%), omental veins (n ¼ 10, 58.8%), short gastric veins (n ¼ 17, 100%), pancreatic veins (n ¼ 1, 5.9%), and esophageal varices (n ¼ 1, 5.9%). In 8 of the 10 patients with gastric varices there was accompanying coronary vein enlargement. In 9 of 10 patients with gastric varices GEVs were also enlarged. In the patient with gastric varices without GEV enlargement we observed a collateral vein directly connecting short gastric veins with portal vein.
In 7 of the 24 patients, splenic vein thrombosis involved the spleno-mesenteric confluence. In this group, gastric varices (n ¼ 6, 85.7%) (isolated fundal varices in 3 patients and varices in both fundus and corpus of the stomach in 3 patients), collateralized right and left gastroepiploic veins (n ¼ 7, 100%), coronary veins (n ¼ 3, 42.9%), omental veins (n ¼ 7, 100%), short gastric veins (n ¼ 7, 100%), pancreatic veins (n ¼ 1, 14.3%) and esophageal varices (n ¼ 2, 28.6%) were observed. In 3 of the 6 patients with gastric varices there was accompanying coronary vein enlargement. In each of the 6 patients with gastric varices GEV enlargement was also present.
Splenomegaly was detected in 11 patients (45.8%), anemia in 13 patients (54.2%), and thrombocytopenia (with or without leukopenia) in 8 patients (33.3%). The splenic volume ranged between 120 mL-1342 mL (mean, median: 426, 333 mL).
Patient demographics and CT findings are detailed in Table 2 .
Upper gastrointestinal endoscopy was performed in 6 patients and revealed gastric varices in 3 patients. Findings were conforming with CT imaging.
None of the patients had a history of gastrointestinal bleeding. Abdominal pain was stated by 23 patients (95.8%). Figures 1 and 2 demonstrate the CT imaging findings of SPH. 
Discussion
In SPH, diagnosis is mainly clinical and often made by exclusion of systemic portal hypertension. Diagnostic imaging is helpful in presenting the underlying causative pathology and associated findings, in particular, collateral pathways [8, 9, 12] .
Splenic vein obstruction may result from thrombosis due to intrinsic (thrombophilia, idiopathic thrombosis, etc.) or extrinsic (neoplasm, pancreatitis, peudocyst, splenic artery aneurysm, etc.) causes. Because splenic vein lies posterior to the pancreas, there is a strong association between pancreatic disorders and splenic vein obstruction. Different studies have suggested either pancreatitis or pancreatic neoplasms as the most common cause [1, 8, 9, 12] . In our study, the most frequent observed pathology leading to SPH was pancreatic adenocarcinoma. This was in keeping with the studies of Cho et al [8] and Marn et al [12] , who also found pancreatic adenocarcinoma to be the most frequent underlying causative pathology in SVO.
It is important to distinguish between sinistral and systemic portal hypertension, as there are signficant differences in management. Although refractory hemorrhage from varices in sinistral portal hypertension is treated with . Although some authors recommend prophylactic splenectomy even in asymptomatic patients with SPH, conservative management is currently favored [14, 19] . As shown by Bradley et al, the main collateral routes in SPH are either via short gastric GEVs or by left short gastric veins [20] . Collateralized omental veins were also reported in association with SVO [8] . Our study is consistent with the literature that enlarged gastroepiploic and short gastric veins are the most frequent collaterals in SPH. Because enlargement of GEVs is not a typical feature of generalized portal hypertension, presence of this collateral should raise concern of splenic vein obstruction [21] . This might be helpful, especially in early pancreatic disease where splenic vein involvement may be obscured and, hence, be overlooked on CT images [11] .
Short gastric veins anastomose in the gastric mucosa and may produce fundal varices, whereas esophageal varices, which develop as a portosystemic collateral pathway, are rarely seen in SPH [4] . Thus, gastric varices without esophageal varices are an expected finding of SVO, owing to the fact that portal venous pressure is within normal limits and hepatopetal flow is preserved via short gastric vein, left gastric vein, and left-right GEVs [3e6,17]. Our study is consistent with the literature because only 3 of the 24 patients had esophageal varices. In 2 of these patients, splenic vein thrombosis was extending into portomesenteric confluence. We suppose that splenic vein thrombosis extending into portomesenteric confluence leads to a diminishment in venous drainage via GEVs into portal vein, and esoephageal varices may develop as a portosystemic drainage route.
Gastrointestinal bleeding is the most severe and lifethreatening complication of SPH [5] . However, GEVs, which are the most common observed collateral in SPH, are described as ''safe'' varices by Bradley et al [20] . Gastric varices were detected in 45% of our patient population, but none of them had a history of gastrointestinal bleeding. This is consistent with other studies that suggest that gastric varices bleed less frequently than esoephageal varices [17, 20, 22] . However, bleeding from gastric varices is associated with a higher mortality than from esophageal varices [6] .
We found that in 15 of the 16 (93.8%) patients with gastric varices, GEVs were enlarged, and the remaining 1 of 16 patients (6.2%) had a venous collateral directly connecting short gastric veins with portal vein. Because none of our patients had a history of gastrointestinal bleeding, we suggest that collateralization of GEV plays a decompressive role and may prevent bleeding due to gastric varices. Therefore, an occlusion of GEV might raise the risk of gastrointestinal bleeding, and thus any CT findings indicative of thrombosis should be reported, especially in patients with splenic vein occlusion.
It has been emphasized that in addition to splenic vein thrombosis with accompanying dilated GEVs, gastric varices, and normal liver function, another indicator of SPH is splenomegaly [23, 24] . On the other hand, some studies stated that splenomegaly may not be seen in SPH [7, 9] . Splenomegaly occurs in SPH owing to splenic arterial inflow and splenic venous congestion.
It can be associated with thrombocytopenia or leukopenia, a condition referred to as hypersplenism [25, 26] . Splenomegaly was detected in 45.8% and thrombocytopenia (with or without leukopenia) was present in 8 patients (33.3%) of our patients.
It is noticeable that, with the exception of 6 cases, there was apparently no clinical indication for upper gastrointestinal endoscopy in our patients, emphasizing that sinistral portal hypertension may be clinically silent. Even though abdominal pain was stated by nearly each patient (n ¼ 23, 95.8%) this clinical finding could also be associated with the primary disease as pancreatic adenocarcinoma or pancreatitis and therefore should be considered as a nonspesific symptom in this patient population. Detection of abdominal venous collaterals and splenomegaly might raise concern of chronic parenchymal liver disease; therefore CT imaging can also play a crucial role in preventing patients with SPH from unnecessary liver biopsy, which is still the gold-standard method in diagnosis of liver cirrhosis, especially in cases of unknown etiology [27] . Thus, if CT reveals SVO in these patients, this should be reported with an indication of SPH and an advice to the attending clinician to consider upper endoscopy for follow-up of esophago-gastric varices.
Our study has several limitations. First, the sample size was relatively small. Second, upper endoscopy was performed only in 6 patients; thus, correlation of CT findings indicative of gastric varices could not be made in most of the patients.
Conclusion
In conclusion, we emphasize that in the presence of gastroepiploic collaterals, splenic vein should be thoroughly checked so that thrombosis is not overlooked, especially if a pancreatic disease exists.
We also suggest that despite formation of multiple collaterals, SPH may not cause any specific symptoms and CT imaging may be the only indicator for this disease, which is actually associated with an elevated bleeding risk.
